Simple blood test may predict lung cancer treatment success
NCT ID NCT04790682
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 29 times
Summary
This study is testing whether a simple blood test (liquid biopsy) can predict how well immunotherapy works in people with advanced lung cancer. Researchers will follow 300 patients who have not yet been treated and are starting immunotherapy, with or without chemotherapy. The goal is to see if changes in tumor DNA in the blood can tell early on whether the treatment is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Ambroise Pare
RECRUITINGBoulogne-Billancourt, 92100, France
Contact
Contact
-
Institut Curie
RECRUITINGParis, 75005, France
Contact
Contact
-
Institut Curie
RECRUITINGSaint-Cloud, 92210, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.